CONSIDERATIONS TO KNOW ABOUT AZELAPRAG FDA APPROVAL

In December, BioAge declared a multi-year study collaboration with Novartis to determine and validate novel therapeutic targets at the intersection of aging biology and physical exercise, combining BioAge's longitudinal human getting older datasets with Novartis expertise in training biology.Even if you decide to just take this knowledge severely,